Effect of phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier

Neurochemical Research

Volumn 37, Issue 9, 2012, Pages 1967-1981

  Rapôso, Catarina ^a   Odorissi, Paulo Alexandre Miranda ^a   Oliveira, Alexandre L R ^a   Aoyama, Hiroshi ^a   Ferreira, Carmen Verissima ^a   Verinaud, Liana ^a   Fontana, Karina ^a   Ruela De Sousa, Roberta R ^a   Da Cruz Höfling, Maria Alice ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Astrocytes; Basement membrane; Blood brain barrier; Efflux protein; Endothelial cells; Spider venom; Tight and adhesion proteins

Indexed keywords

ADHESION JUNCTIONAL PROTEIN; BETA CATENIN; CLAUDIN 5; LAMININ; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; OCCLUDIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN ZO1; SPIDER VENOM; TIGHT JUNCTIONAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; CELL INTERACTION; CELL TRANSPORT; CEREBELLUM; CONTROLLED STUDY; ENVENOMATION; ENZYME INHIBITION; FLOW CYTOMETRY; HIPPOCAMPUS; IN VITRO STUDY; INCUBATION TIME; MALE; NERVE FUNCTION; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; PHONEUTRIA NIGRIVENTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SPIDER; TOXICOKINETICS;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CEREBELLUM; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; LAMININ; MALE; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; NEUROTOXICITY SYNDROMES; NEUROTOXINS; P-GLYCOPROTEIN; PHOSPHORYLATION; RATS; RATS, WISTAR; SPIDER VENOMS; SPIDERS;

ARANEAE; PHONEUTRIA NIGRIVENTER;

EID: 84866742503     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0817-y     Document Type: Article

References (40)

1. Bucaretchi F, Deus Reinaldo CR, Hyslop S, Madureira PR, De Captani EM, Vieira RJ (2000) A clinico-epidemiological study of bites by spiders of the genus Phoneutria. Rev Inst Med Trop Sao Paulo 42:17-21
2. Antunes E, Marangoni RA, Brain SD, Nucci G (1992) Phoneutria nigriventer (armed spider) venom induces increased vascular permeability in rat and rabbit skin in vivo. Toxicon 30:1011-1016
3. Costa SK, Moreno H Jr, Brain SD, De Nucci G, Antunes E (1996) The effect of Phoneutria nigriventer (armed spider) venom on arterial blood pressure of anaesthetised rats. Eur J Pharmacol 298:113-120
4. Estato V, Antunes E, Machado B, De Nucci G, Tibiriçá E (2000) Investigation of the haemodynamic effects of Phoneutria nigriventer venom in anaesthetized rabbits. Toxicon 38:841-853
5. Costa SKP, Nucci G, Antunes E, Brain SD (1997) Phoneutria nigriventer spider venom induces oedema in rat skin by activation of capsaicin sensory nerves. Eur J Pharmacol 339:223-226
6. Costa SKP, Esquisatto LCM, Camargo E, Gambero A, Brain SD, De Nucci G, Antunes E (2001) Comparative effect of Phoneutria nigriventer spider venom and capsaicin on the rat paw oedema. Life Sci 69:1573-1585
7. Nunes KP, Costa-Gonçalves A, Lanza LF, Cortes SF, Cordeiro MN, Richardson M, Pimenta AM, Webb Rc, Leite R, De Lima ME (2008) T2-6 toxin of the Phoneutria nigriventer spider potentiates rat erectile function. Toxicon 51:1197-1206
8. Bucaretchi F, Mello SM, Vieira RJ, Mamoni RL, Blotta HSL, Antunes E, Hyslop S (2008) Systemic envenomation caused by the wandering spider Phoneutria nigriventer, with quantification of circulating venom. Clin Toxicol 46:885-889
9. Le Sueur LP, Kalapothakis E, Cruz-Höfling MA (2003) Breakdown of the blood-brain barrier and neuropathological changes induced by Phoneutria nigriventer spider venom. Acta Neuropathol 105:125-134
10. Le Sueur LP, Collares-Buzato CB, Cruz-Höfling MA (2004) Mechanisms involved in the blood-brain barrier increased permeability induced by Phoneutria nigriventer spider venom in rats. Brain Res 1027:38-47
11. Cruz-Höfling MA, Zago GM, Melo LL, Rapôso C (2007) c-FOS and n-NOS reactive neurons in response to circulating Phoneutria nigriventer spider venom. Brain Res Bull 73:114-126
12. Cruz-Höfling MA, Rapôso C, Verinaud L, Zago GM (2009) Neuroinflammation and astrocytic reaction in the course of Phoneutria nigriventer (armed-spider) blood-brain barrier (BBB) opening. NeuroToxicology 30:636-646
13. Rapôso C, Zago GM, da Silva GH, da Cruz Höfling MA (2007) Acute blood-brain barrier permeabilization in rats after systemic Phoneutria nigriventer venom. Brain Res 1149:18-29
14. Staddon JM, Herrenknecht K, Smales C, Rubin LL (1995) Evidence that tyrosine phosphorylation may increase tight junction permeability. J Cell Sci 108:609-619
15. Rubin LL, Staddon JM (1999) The cell biology of the blood- brain barrier. Annu Rev Neurosci 22:11-28
16. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902
17. 2+ entry linked to rapid glutamate release: studies using the Phoneutria nigriventer toxin PhTX2 and potassium depolarization. Biochem J 296:313-319
18. Rubin LL, Hall DE, Porter S, Barbu K, Cannon C, Horner HC, Janatpour M, Liaw CW, Manning K, Morales J, Tanner LI, Tomaselli KJ, Bard F (1991) A cell culture model of the bloodbrain barrier. J Cell Biol 115:1725-1735
19. Geiger B, Volk T, Volberg T, Bendor R (1987) Molecular interactions in adherens type contacts. J Cell Sci 8:251-272
20. Jockusch BM, Rüdiger M (1996) Crosstalk between cell adhesion molecules: vinculin as a paradigm for regulation by conformation. Trends Cell Biol 6:311-315
21. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA (1986) Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 103:755-766
22. Willott E, Balda MS, Heintzelman M, Jameson B, Anderson JM (1992) Localization and differential expression of two isoforms of the tight junction protein ZO-1. Am J Physiol 262:C1119- C1124
23. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE (1996) Occludin is a functional component of the tight junction. J Cell Sci 109: 2287-2298
24. Furuse M, Furuse K, Sasaki H, Tsukita S (2001) Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153:263-272
25. Staddon JM, Herrenknecht K, Schulze C, Smales C, Rubin LL (1995) Signal transduction at the blood-brain barrier. Biochem Soc Trans 23:475-479
26. Roura S, Miravet S, Piedra J, García de Herreros A, Duñach M (1999) Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J Biol Chem 274:36734-36740
27. Gaudry CA, Palka HL, Dusek RL, Huen AC, Handekar MJ, Hudson LG, Green KJ (2001) Tyrosine-phosphorylated plakoglibin is associated with desmogleins but not desmoplakin after epidermal growth factor receptor activation. J Biol Chem 276:24871-24880
28. Nita-Lazar M, Rebustini I, Walker J, Kukuruzinska MA (2010) Hypoglycosylated E-cadherin promotes the assembly of tight junctions through the recruitment of PP2A to adherens junctions. Exp Cell Res 316:1871-1884
29. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22:1942-1950
30. Nunbhakdi-Craig V, Machleidt T, Ogris E, Bellotto D, White CL, Sontag E (2002) Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 158:967-978
31. Takahashi K, Nakajima E, Suzuki K (2006) Involvement of protein phosphatase 2A in the maintenance of E-cadherin- mediated cell-cell adhesion through recruitment of IQGAP1. J Cell Physiol 206:814-820
32. Nita-Lazar M, Noonan V, Rebustini I, Walker J, Menko AS, Kukuruzinska MA (2009) Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer. Cancer Res 69:5673-5680
33. Hartz AMS, Madole EK, Miller DS, Bauer B (2010) Tensin homolog/phosphoinositide 3-Kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein. J Pharmacol Exp Ther 334:467-476
34. Bolton SJ, Anthony DC, Perry VH (1998) Loss of tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86:1245-1257
35. Bernacki J, Dobrowolska A, Nierwinka K, Malecki A (2008) Physiology and pharmacological role of the blood-brain barrier. Pharmacol Rep 60:600-622
36. Bodo A, Bakos E, Szeri F, Varadi A, Sarkadi B (2003) The role of multidrug transporter in drug availability, metabolim and toxicity. Toxicol Lett 140-141:133-143
37. Fromm MF (2003) Importance of P-glycoprotein for drug disposition in humans. Eur J Clin Invest 33(Suppl 2):6-9
38. Abbott NJ (2002) Astrocyte-endothelial interactions and bloodbrain barrier permeability. J Anat 200:527
39. Kuteykin-Teplyakov K, Brandt C, Hoffmann K, Löscher W (2009) Complex time-dependent alterations in the brain expression of different drug efflux transporter genes after status epilepticus. Epilepsia 50:887-897
40. Saubaméa B, Cochois-Guégan V, Cisternino S, Scherrmann JM (2012) Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression. J Cereb Blood Flow Metab 32:81-92